Abstract
Background
Complementary ozone therapy has been identified as a revolutionary medical technique for a number of goals and ailments. At the present, it has been shown that ozone has medicinal qualities, such as antibacterial, antifungal, and antiparasitic properties. Coronavirus (SARS-CoV-2) is quickly spread over the globe. Cytokine storms and oxidative stress seem to play a substantial role in the most of acute attacks of the disease. The aim of this research was to assess the therapeutic advantages of complementary ozone therapy on the cytokine profile and antioxidant status in COVID-19 patients.
Methods
The statistical sample of this study included two hundred patients with COVID-19. One hundred COVID-19 patients (treatment group) received 240 ml of the patient's blood and an equal volume of O2/O3 gas at a concentration of 35–50 μg/ml daily, which gradually increased in concentration, and were kept for 5–10 days and one hundred patients (control group) received standard treatment. The secretion levels of IL-6, TNF-α, IL-1β, IL-10 cytokines, SOD, CAT and GPx were compared between control patients (standard treatment) and standard treatment plus intervention (ozone) before and after treatment.
Results
The findings indicated a significant decrease in the level of IL-6, TNF-α, IL-1β in group receiving complementary ozone therapy in compared with control group. Furthermore, a significant increase was found in the level of IL-10 cytokine. Moreover, SOD, CAT and GPx levels revealed a significant increase in complementary ozone therapy group compared to control group.
Conclusions
Our results revealed that complementary ozone therapy can be used as a medicinal complementary therapy to reduce and control inflammatory cytokines and oxidative stress status in patients with COVID-19 as revealed its antioxidant and anti-inflammatory effects.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
The data sets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
References
Cattel F, Giordano S, Bertiond C, Lupia T, Corcione S, Scaldaferri M, Angelone L, De Rosa FG (2021) Ozone therapy in COVID-19: A narrative review. Virus Res 291:198207. https://doi.org/10.1016/j.virusres.2020.198207
Cenci A, Macchia I, La Sorsa V, Sbarigia C, Di Donna V, Pietraforte D (2022) Mechanisms of action of ozone therapy in emerging viral diseases: immunomodulatory effects and therapeutic advantages with reference to SARS-CoV-2. Front Microbiol 13:871645. https://doi.org/10.3389/fmicb.2022.871645
Çolak Ş, Genç Yavuz B, Yavuz M, Özçelik B, Öner M, Özgültekin A, Şenbayrak S (2021) Effectiveness of ozone therapy in addition to conventional treatment on mortality in patients with COVID-19. Int J Clin Pract 75(8):e14321. https://doi.org/10.1111/ijcp.14321
Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M (2020) The cytokine storm in COVID-19: An overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev 53:25–32. https://doi.org/10.1016/j.cytogfr.2020.05.003
Forcados GE, Muhammad A, Oladipo OO, Makama S, Meseko CA (2021) Metabolic implications of oxidative stress and inflammatory process in SARS-CoV-2 pathogenesis: therapeutic potential of natural antioxidants. Front Cell Infect Microbiol 11:654813. https://doi.org/10.3389/fcimb.2021.654813
Galiè M, Covi V, Tabaracci G, Malatesta M (2019) The role of Nrf2 in the antioxidant cellular response to medical ozone exposure. Int J Mol Sci 20(16):4009. https://doi.org/10.3390/ijms20164009
Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, Lekoubou A, Oh JS, Ericson JE, Ssentongo P, Chinchilli VM (2021) Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open 4(10):e2128568. https://doi.org/10.1001/jamanetworkopen.2021.28568
Hernández A, Viñals M, Isidoro T, Vilás F (2020) Potential role of oxygen-ozone therapy in treatment of COVID-19 pneumonia. Am J Case Rep. 21:e925849. https://doi.org/10.12659/AJCR.925849
Khan Z, Karataş Y, Rahman H (2020) Anti COVID-19 drugs: need for more clinical evidence and global action. Adv Ther 37(6):2575–2579. https://doi.org/10.1007/s12325-020-01351-9
Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 55(3):105924. https://doi.org/10.1016/j.ijantimicag.2020.105924
Martínez-Sánchez G, Schwartz A, Donna VD (2020) Potential cytoprotective activity of ozone therapy in SARS-CoV-2/COVID-19. Antioxidants (basel) 9(5):389. https://doi.org/10.3390/antiox9050389
Ogut E, Yildirim FB, Sarikcioglu L, Aydin MA, Demir N (2020) Neuroprotective effects of ozone therapy after sciatic nerve cut injury. Kurume Med J 65(4):137–144. https://doi.org/10.2739/kurumemedj.MS654002
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A (2017) Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017:8416763. https://doi.org/10.1155/2017/8416763
Rabaan AA, Al-Ahmed SH, Muhammad J, Khan A, Sule AA, Tirupathi R, Mutair AA, Alhumaid S, Al-Omari A, Dhawan M, Tiwari R, Sharun K, Mohapatra RK, Mitra S, Bilal M, Alyami SA, Emran TB, Moni MA, Dhama K (2021) Role of inflammatory cytokines in COVID-19 patients: a review on molecular mechanisms, immune functions, immunopathology and immunomodulatory drugs to counter cytokine storm. Vaccines (basel) 9(5):436. https://doi.org/10.3390/vaccines9050436
Ragab D, Salah Eldin H, Taeimah M, Khattab R, Salem R (2020) The COVID-19 cytokine storm; what we know so far. Front Immunol 16(11):1446. https://doi.org/10.3389/fimmu.2020.01446
Rowen RJ, Robins H (2020) A plausible, “penny” costing effective treatment for corona virus - ozone therapy. J Infect Dis Epidemiol 6:113. https://doi.org/10.23937/2474-3658/1510113
Scassellati C, Galoforo AC, Bonvicini C, Esposito C, Ricevuti G (2020) Ozone: a natural bioactive molecule with antioxidant property as potential new strategy in aging and in neurodegenerative disorders. Ageing Res Rev 63:101138. https://doi.org/10.1016/j.arr.2020.101138
Sharifi-Rad M, Anil Kumar NV, Zucca P, Varoni EM, Dini L, Panzarini E, Rajkovic J, Tsouh Fokou PV, Azzini E, Peluso I, Prakash Mishra A, Nigam M, El Rayess Y, Beyrouthy ME, Polito L, Iriti M, Martins N, Martorell M, Docea AO, Setzer WN, Calina D, Cho WC, Sharifi-Rad J (2020) Lifestyle, oxidative stress, and antioxidants: back and forth in the pathophysiology of chronic diseases. Front Physiol 2(11):694. https://doi.org/10.3389/fphys.2020.00694
Sharma A, Ahmad Farouk I, Lal SK (2021) COVID-19: a review on the novel coronavirus disease evolution, transmission, detection, control and prevention. Viruses 13(2):202. https://doi.org/10.3390/v13020202
Shimabukuro-Vornhagen A, Gödel P, Subklewe M, Stemmler HJ, Schlößer HA, Schlaak M, Kochanek M, Böll B, von Bergwelt-Baildon MS (2018) Cytokine release syndrome. J Immunother. Cancer 6(1):56. https://doi.org/10.1186/s40425-018-0343-9
Acknowledgements
The authors wish to thank all staff of Baqiyatallah Hospital (Tehran, Iran) and Ozone research center of Baqiyatallah university of medical science and Seyed Alireza Mirilavasani, and Ali Asghar Akhlaghi for their cooperation in implementing experimental procedures and analysis of data.
Funding
Not applicable.
Author information
Authors and Affiliations
Contributions
All authors contributed substantially in the design, implementation of the study and data collection, and wrote the first draft of the manuscript and performed statistical analysis. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethics approval and consent to participate
This study was conducted in compliance with the declaration of Helsinki. The study was approved by the Institutional Review Board of, Baqiyatallah University of Medical Sciences.
Consent for publication
Not applicable.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Ghaleh, H.E.G., Izadi, M., Javanbakht, M. et al. Cytokine profile and antioxidants status in the moderate and severe COVID-19 patients: a trial of ozone therapy impact as a medicinal supplement. Inflammopharmacol 31, 3029–3036 (2023). https://doi.org/10.1007/s10787-023-01288-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10787-023-01288-9